Tan KT - Search Results

1

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer.

Chen TW, Hsiao W, Dai MS, Lin CH, Chang DY, Chen IC, Wang MY, Chang SH, Huang SM, Cheng AL, Wu KW, Tan KT, Lu YS. Chen TW, et al. Among authors: tan kt. Breast Cancer Res Treat. 2023 Oct;201(3):377-385. doi: 10.1007/s10549-023-06967-3. Epub 2023 Jun 21. Breast Cancer Res Treat. 2023. PMID: 37344660 Free PMC article.

2

TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer.

Hsu HC, You JF, Chen SJ, Chen HC, Yeh CY, Tsai WS, Hung HY, Yang TS, Lapke N, Tan KT. Hsu HC, et al. Among authors: tan kt. Cancers (Basel). 2019 Jul 30;11(8):1079. doi: 10.3390/cancers11081079. Cancers (Basel). 2019. PMID: 31366114 Free PMC article.

3

Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders.

Lin PH, Tseng LM, Lee YH, Chen ST, Yeh DC, Dai MS, Liu LC, Wang MY, Lo C, Chang S, Tan KT, Chen SJ, Kuo SH, Huang CS. Lin PH, et al. Among authors: tan kt. J Formos Med Assoc. 2022 Dec;121(12):2538-2547. doi: 10.1016/j.jfma.2022.05.015. Epub 2022 Jun 23. J Formos Med Assoc. 2022. PMID: 35752529 Free article.

4

Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer.

Chao A, Chen SJ, Chen HC, Tan KT, Hsiao W, Jung SM, Yang LY, Huang KG, Chou HH, Huang HJ, Chang TC, Chao AS, Lee YH, Wu RC, Lai CH. Chao A, et al. Among authors: tan kt. Biomed J. 2023 Oct;46(5):100563. doi: 10.1016/j.bj.2022.09.004. Epub 2022 Oct 5. Biomed J. 2023. PMID: 36208860 Free PMC article.

5

Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing.

Jan YH, Tan KT, Chen SJ, Yip TTC, Lu CT, Lam AK. Jan YH, et al. Among authors: tan kt. Br J Cancer. 2022 Oct;127(7):1304-1311. doi: 10.1038/s41416-022-01913-4. Epub 2022 Jul 16. Br J Cancer. 2022. PMID: 35842545 Free PMC article.

6

Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.

Chiang NJ, Tan KT, Bai LY, Hsiao CF, Huang CY, Hung YP, Huang CJ, Chen SC, Shan YS, Chao Y, Huang YH, Lee IC, Lee PC, Su YY, Chen SJ, Yeh CN, Chen LT, Chen MH. Chiang NJ, et al. Among authors: tan kt. Clin Cancer Res. 2022 Oct 3;28(19):4248-4257. doi: 10.1158/1078-0432.CCR-22-1152. Clin Cancer Res. 2022. PMID: 35849151 Free PMC article. Clinical Trial.

7

Concomitant Genetic Alterations are Associated with Worse Clinical Outcome in EGFR Mutant NSCLC Patients Treated with Tyrosine Kinase Inhibitors.

Chang SC, Lai YC, Chang CY, Huang LK, Chen SJ, Tan KT, Yu PN, Lai JI. Chang SC, et al. Among authors: tan kt. Transl Oncol. 2019 Nov;12(11):1425-1431. doi: 10.1016/j.tranon.2019.07.008. Epub 2019 Aug 8. Transl Oncol. 2019. PMID: 31401335 Free PMC article.

8

Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.

Ong PY, Poon SL, Tan KT, Putti TC, Ow SGW, Chen SJ, Chen CH, Lee SC. Ong PY, et al. Among authors: tan kt. Gynecol Oncol. 2019 Nov;155(2):275-279. doi: 10.1016/j.ygyno.2019.08.027. Epub 2019 Aug 31. Gynecol Oncol. 2019. PMID: 31481248

9

Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast Cancer.

Cheng FT, Lapke N, Wu CC, Lu YJ, Chen SJ, Yu PN, Liu YT, Tan KT. Cheng FT, et al. Among authors: tan kt. Case Rep Oncol Med. 2019 Sep 10;2019:6545298. doi: 10.1155/2019/6545298. eCollection 2019. Case Rep Oncol Med. 2019. PMID: 31583146 Free PMC article.

10

Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab.

Tao CW, Chen MY, Tseng CM, Lapke N, Chen SJ, Tan KT. Tao CW, et al. Among authors: tan kt. Case Rep Oncol Med. 2020 Mar 1;2020:9072173. doi: 10.1155/2020/9072173. eCollection 2020. Case Rep Oncol Med. 2020. PMID: 32190395 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

391 results

Search Page